Wells Fargo raised the firm’s price target on Pennant Group (PNTG) to $31 from $30 and keeps an Equal Weight rating on the shares. The firm cites a strong Q1 across segments, with Home Health & Hospice outperformance as more notable. Wells is increasing estimates based on Q1 performance, high-end of guidance commentary and positive update on Signature integration process.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PNTG: